Colorable role of interleukin (IL)-6 in obesity hypertension: A hint from a Chinese adult case-control study

Ou Wu1, Chengda Yuan2, Jianhang Leng3

  • 1Shulan International Medical College, Zhejiang Shuren University, Zhejiang, China.

Cytokine
|May 26, 2023
PubMed

Insights

Interleukin-6 (IL-6) shows varied effects in obesity-hypertension, influencing blood pressure and inflammation differently based on disease presence. Further research is needed to understand IL-6

Area of Science:

  • Cardiovascular Disease Research
  • Immunology and Inflammation
  • Metabolic Disorders

Background:

  • Obesity and hypertension are leading global risk factors for cardiovascular diseases.
  • Both conditions are linked to chronic low-grade inflammation mediated by cytokines like interleukin-6 (IL-6).
  • The precise role of IL-6 in hypertension associated with obesity remains unclear.

Purpose of the Study:

  • To investigate the impact of IL-6 on blood pressure, inflammation, and metabolic function in individuals with obesity and hypertension.
  • To conduct a case-control study in a Chinese adult population.

Main Methods:

  • 153 participants were categorized into four groups: normal healthy (NH), obesity only (JO), hypertension only (JH), and obesity-hypertension (OH).
  • Serum IL-6 concentrations were quantified using Enzyme-linked Immunosorbent Assay (ELISA).
  • Correlations between IL-6 levels and anthropometric/laboratory parameters were analyzed, alongside differences across subgroups. Multiple linear regression identified predictors of serum IL-6.

Main Results:

  • Serum IL-6 was higher in the NH group compared to the JO group.
  • Positive correlation between IL-6 and diastolic blood pressure was observed in NH and JO groups, but not in JH and OH groups.
  • IL-6 correlated with albumin (NH), alkaline phosphatase (JO), serum creatinine, and fasting blood glucose (JH). Predictors of IL-6 varied significantly across groups.

Conclusions:

  • IL-6 appears to exert diverse effects in the pathogenesis of obesity-hypertension, influenced by the presence of either or both conditions.
  • Further investigation is required to fully elucidate the mechanisms of IL-6 signaling and its functional role in these diseases.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
552
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.8K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
27